IFITM1 | Interferon induced transmembrane protein 1 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
PKP3 | Plakophilin 3 | Plasma proteins
| | | | | Tissue enhanced |
IRF7 | Interferon regulatory factor 7 | Transcription factors
| | | | | Expressed in all |
TALDO1 | Transaldolase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MUC5AC | Mucin 5AC, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Tissue enriched |
CTSD | Cathepsin D | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
STIM1 | Stromal interaction molecule 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
TRIM21 | Tripartite motif containing 21 | Plasma proteins
| | | | | Expressed in all |
PRKCDBP | Protein kinase C, delta binding protein | | | | | | Mixed |
TAF10 | TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa | | | | | | Expressed in all |
EIF3F | Eukaryotic translation initiation factor 3, subunit F | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
WEE1 | WEE1 G2 checkpoint kinase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
SWAP70 | SWAP switching B-cell complex 70kDa subunit | | | | | | Expressed in all |
MICAL2 | Microtubule associated monooxygenase, calponin and LIM domain containing 2 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Expressed in all |
COPB1 | Coatomer protein complex, subunit beta 1 | Plasma proteins
| | | | | Expressed in all |
PSMA1 | Proteasome (prosome, macropain) subunit, alpha type, 1 | Enzymes
| | | | | Expressed in all |
GTF2H1 | General transcription factor IIH, polypeptide 1, 62kDa | Cancer-related genes
| | | | | Expressed in all |
TSG101 | Tumor susceptibility 101 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PRMT3 | Protein arginine methyltransferase 3 | Predicted membrane proteins
| | | | | Expressed in all |
RCN1 | Reticulocalbin 1, EF-hand calcium binding domain | Predicted secreted proteins
| | | | | Expressed in all |
EIF3M | Eukaryotic translation initiation factor 3, subunit M | | | | | | Expressed in all |
CSTF3 | Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa | | | | | | Expressed in all |
CD59 | CD59 molecule, complement regulatory protein | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APIP | APAF1 interacting protein | Enzymes
| | | | | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
TP53I11 | Tumor protein p53 inducible protein 11 | Predicted membrane proteins
| | | | | Expressed in all |
ARHGAP1 | Rho GTPase activating protein 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes
| | | | | Expressed in all |
SPI1 | Spleen focus forming virus (SFFV) proviral integration oncogene | Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
PSMC3 | Proteasome (prosome, macropain) 26S subunit, ATPase, 3 | Plasma proteins
| | | | | Expressed in all |
CELF1 | CUGBP, Elav-like family member 1 | Plasma proteins
| | | | | Expressed in all |
TNKS1BP1 | Tankyrase 1 binding protein 1, 182kDa | Cytoskeleton related proteins
| | | | | Expressed in all |
CLP1 | Cleavage and polyadenylation factor I subunit 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CTNND1 | Catenin (cadherin-associated protein), delta 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
LPXN | Leupaxin | | | | | | Expressed in all |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CCDC86 | Coiled-coil domain containing 86 | | | | | | Expressed in all |
PRPF19 | Pre-mRNA processing factor 19 | Plasma proteins
| | | | | Expressed in all |
CD6 | CD6 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AHNAK | AHNAK nucleoprotein | Plasma proteins
| | | | | Expressed in all |
MTA2 | Metastasis associated 1 family, member 2 | Plasma proteins Transcription factors
| | | | | Expressed in all |
GANAB | Glucosidase, alpha; neutral AB | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
UBXN1 | UBX domain protein 1 | | | | | | Expressed in all |
RTN3 | Reticulon 3 | Predicted membrane proteins
| | | | | Expressed in all |
MARK2 | MAP/microtubule affinity-regulating kinase 2 | Enzymes
| | | | | Expressed in all |